Aldeyra Therapeutics, Inc. - Common Stock (NQ:ALDX)
5.500
+0.010
(+0.18%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 26, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 937,438 |
| Open | 5.470 |
| Bid (Size) | 5.410 (100) |
| Ask (Size) | 5.500 (500) |
| Prev. Close | 5.490 |
| Today's Range | 5.350 - 5.535 |
| 52wk Range | 1.140 - 7.200 |
| Shares Outstanding | 58,576,350 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
These stocks are moving in today's session ↗
December 16, 2025
4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals ↗
October 10, 2025
4 Biotech Stocks Seeing Explosive Momentum Gains ↗
October 07, 2025
Frequently Asked Questions
Is Aldeyra Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aldeyra Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aldeyra Therapeutics, Inc. - Common Stock trade on?
Aldeyra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aldeyra Therapeutics, Inc. - Common Stock?
The ticker symbol for Aldeyra Therapeutics, Inc. - Common Stock is ALDX on the Nasdaq Stock Market
What is the current price of Aldeyra Therapeutics, Inc. - Common Stock?
The current price of Aldeyra Therapeutics, Inc. - Common Stock is 5.500
When was Aldeyra Therapeutics, Inc. - Common Stock last traded?
The last trade of Aldeyra Therapeutics, Inc. - Common Stock was at 02/26/26 04:00 PM ET
What is the market capitalization of Aldeyra Therapeutics, Inc. - Common Stock?
The market capitalization of Aldeyra Therapeutics, Inc. - Common Stock is 322.17M
How many shares of Aldeyra Therapeutics, Inc. - Common Stock are outstanding?
Aldeyra Therapeutics, Inc. - Common Stock has 322M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.